6 results about "Equine Encephalitis" patented technology

Disclosed are halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections. Such viral infections can include enterovirus, tongaviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infections.

To provide pharmaceutical compositions and methods for the treatment of viral infections.SOLUTION: Halogen-containing nucleotide and nucleoside therapeutic compositions and uses related thereto are disclosed. In certain embodiments, the disclosure relates to the treatment or prevention of viral infections. Such viral infections may include togaviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, eastern equine encephalitis, western equine encephalitis, and Venezuelan equine encephalitis (EEE, WEE, and VEE, respectively), chikungunya (CHIK), Ebola, flu, RSV, and Zika virus infections.SELECTED DRAWING: Figure 1

Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses thereof are disclosed. In certain embodiments, the disclosure relates to the treatment or prevention of viral infections. Such viral infections may include enterovirus, tapiviridae, bunyaviridae, arenaviridae, coronaviridae, flaviviridae, picornaviridae, eastern equine encephalitis, western equine encephalitis, and Venezuela equine encephalitis (EEE, WEE, and VEE, respectively), Chikungunya fever (CHIK), Ebola, influenza, RSV, and Zika virus infections.

The present disclosure is directed to antibodies binding to and neutralizing Venezuelan Equine Encephalitis Vims (VEEV) and methods for use thereof.

To provide a novel treatment for viral infections. [Solution] Halogen-containing nucleotide and nucleoside therapeutic compositions and related uses are disclosed. In certain embodiments, the disclosure relates to the treatment or prevention of viral infections. Such viral infections may include Togaviridae, Bunyaviridae, Arenaviridae, Coronaviridae, Flaviviridae, Picornaviridae, Eastern equine encephalitis, Western equine encephalitis, and Venezuelan equine encephalitis (EEE, WEE, and VEE, respectively), Chikungunya fever (CHIK), Ebola, influenza, RSV, and Zika virus infection. In exemplary embodiments, the compound is selected from the following: TIFF2026062641000590.tif42170

To provide specific N4-hydroxycytidine derivatives, pharmaceutical compositions, and related methods. [Solution] In certain embodiments, this disclosure relates to the treatment or prevention of viral infections such as Eastern equine encephalitis, Western equine encephalitis, and Venezuelan equine encephalitis (EEE, WEE, and VEE, respectively), Chikungunya fever (CHIK), Ebola, influenza, RSV, and Zika virus infection, by the compounds disclosed. In certain embodiments, this disclosure intends to provide derivatives of the compounds disclosed herein, such as compounds containing one or more of the same or different substituents.